Figure 3

Ideogram with chromosomal regions used by predictive genomic model and the highlighted candidate genes in these regions. (A) In patients with vs. without recurrence/metastasis - first phase of the predictive model; (B) in patients without recurrence and those unidentifiable - second phase of the predictive model; (C) in patients with recurrence and those unidentifiable - third phase of the predictive model. Blue represents the proportion of copy number gains and red represents the copy number losses identified in these specific chromosomal regions both in our HNSCC patients and in TCGA database.